Clinical Trial Update: Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This update discusses the results of a Phase 2 trial evaluating panitumumab (ABX-EGF) in patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-06-03